Journal of the American Academy of Dermatology
Volume 61, Issue 1 , Pages 117-120 , July 2009

Alveolar soft part sarcoma presenting with cutaneous metastases: Report of a case with immunohistochemical and molecular characterization

  • Susana Moyano, MD

      Affiliations

    • Department of Pathology, Hospital Clínic, IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), University of Barcelona, Barcelona, Spain
  • ,
  • Paula Aguilera, MD

      Affiliations

    • Department of Dermatology, Hospital Clínic, University of Barcelona, Barcelona, Spain
  • ,
  • Anna Petit, MD

      Affiliations

    • Department of Pathology, Hospital Clínic, IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), University of Barcelona, Barcelona, Spain
  • ,
  • Enrique de Alava, MD, PhD

      Affiliations

    • Centro de Investigación del Cáncer-IBMCC (Instituto de Biología Molecular y Celular del Cáncer), University of Salamanca-CSIC (Consejo Superior de Investigaciones Científicas), Salamanca, Spain
  • ,
  • Jose M. Mascaró, MD, PhD

      Affiliations

    • Department of Dermatology, Hospital Clínic, University of Barcelona, Barcelona, Spain
  • ,
  • Josep Palou, MD

      Affiliations

    • Department of Dermatology, Hospital Clínic, University of Barcelona, Barcelona, Spain
  • ,
  • Joan Ferrando, MD, PhD

      Affiliations

    • Department of Dermatology, Hospital Clínic, University of Barcelona, Barcelona, Spain
  • ,
  • Llucia Alos, MD, PhD

      Affiliations

    • Department of Pathology, Hospital Clínic, IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), University of Barcelona, Barcelona, Spain
    • Corresponding Author InformationReprint requests: Llucia Alos, MD, PhD, Department of Pathology, Hospital Clínic, Villarroel 170, 08036- Barcelona, Spain.

References 

  1. Anderson ME, Hornicek FJ, Gebhardt MC, Raskin KA, Mankin HJ. Alveolar soft part sarcoma: a rare and enigmatic entity. Clin Orthop. 2005;438:144–148
  2. Lieberman PH, Brennan MF, Kimmel M, Erlandson RA, Garin-Chesa P, Flehinger BY. Alveolar soft part sarcoma: a clinico-pathologic study of half a century. Cancer. 1989;63:1–13
  3. Portera CA, Ho V, Patel SR, Hunt KK, Feig BW, Respondek PM, et al. Alveolar soft part sarcoma: clinical course and patterns of metastasis in 70 patients treated at a single institution. Cancer. 2001;91:585–591
  4. Weiss SW, Goldblum JR. Malignant soft tissue tumors of uncertain type. In:  Weiss SW,  Goldblum JR editor. Enzinger and Weiss's soft tissue tumors. 5th ed.. Philadelphia: Mosby; 2008;p. 1182–1191
  5. Ordonez N, Ladanyi M. Alveolar soft part sarcoma. In:  Fletcher CDM,  Unni KK,  Mertens F editor. World Health Organization classification of tumors: pathology and genetics of tumors of soft tissue and bone. Lyon (France): IARC Press; 2002;p. 208–210
  6. Auerbach HE, Brooks JJ. Alveolar soft part sarcoma: a clinicopathologic and immunohistochemical study. Cancer. 1987;60:66–73
  7. van Ruth S, van Coevorden F, Peterse JL, Kroon BBR. Alveolar soft part sarcoma: a report of 15 cases. Eur J Cancer. 2002;38:1324–1328
  8. Mathew T. Evidence supporting neural crest origin of an alveolar soft part sarcoma: an ultrastructural study. Cancer. 1982;50:507–514
  9. Miettinen M, Ekfors T. Alveolar soft part sarcoma: immunohistochemical evidence for muscle cell differentiation. Am J Clin Pathol. 1990;93:32–38
  10. Rosai J, Dias P, Parham DM, Sharipo DN, Houghton P. MyoD1 protein expression in alveolar soft part sarcoma as confirmatory evidence of its skeletal muscle nature. Am J Surg Pathol. 1991;15:974–981
  11. Sciot R, Dal Cin P, de Vos R, van Damme B, de Wever I, van der Berghe H, et al. Alveolar soft part sarcoma: evidence for its myogenic origin and for the involvement of 17q25. Histopathology. 1993;23:43–44
  12. Ladanyi M, Lui MY, Antonescu CR, Krause-Boehm A, Meindl A, Argani P, et al. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene. 2001;20:48–57
  13. Argani P, Lal P, Hutchinson B, Lui MY, Reuter V, Ladanyi M. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay. Am J Surg Pathol. 2003;27:750–761
  14. Argani P, Antonescu CR, Illei PB, Lui MY, Timmons CF, Newbury R, et al. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol. 2001;159:179–192
  15. Vistica DT, Krosky PM, Kenney S, Raffeld M, Shoemaker RH. Immunohistochemical discrimination between the ASPL-TFE3 fusion proteins of alveolar soft part sarcoma. J Pediatr Hematol Oncol. 2008;30:46–52
  16. Deyrup AT, Althof P, Zhou M, Morgan M, Solomon AR, Bridge JA, et al. Paraganglioma-like dermal melanocytic tumor: a unique entity distinct from cellular blue nevus, clear cell sarcoma, and cutaneous melanoma. Am J Surg Pathol. 2004;28:1579–1586
  17. Swetter SM, Ecker PM, Johnson DL, Harvell JD. Primary dermal melanoma: a distinct subtype of melanoma. Arch Dermatol. 2004;140:99–103
  18. Volmar KE, Cummings TJ, Wang WH, Creager AJ, Tyler DS, Xie HB. Clear cell hidradenoma: a mimic of metastatic clear cell tumors. Arch Pathol Lab Med. 2005;129:e113–e116
  19. Ohta M, Hiramoto M, Fujii M, Togo T. Nodular hidradenocarcinoma on the scalp of a young woman: case report and review of literature. Dermatol Surg. 2004;30:1265–1268
  20. Saadat P, Cesnorek S, Ram R, Kelly L, Vadmal M. Primary cutaneous paraganglioma of the scalp. J Am Acad Dermatol. 2006;54(Suppl):S220–S223
  21. Liegl B, Hornick JL, Fletcher CDM. Primary cutaneous PEComa: distinctive clear cell lesions of skin. Am J Surg Pathol. 2008;32:608–614
  22. Mentzel T, Reisshauer S, Rütten A, Hantschke M. Soares de Almeida LM, Kutzner H. Cutaneous clear cell myomelanocytic tumor: a new member of the growing family of perivascular epithelioid cell tumors (PEComas): clinicopathological and immunohistochemical analysis of seven cases. Histopathology. 2005;46:498–504

 Funding sources: None.

 Conflicts of interest: None declared.

PII: S0190-9622(08)01367-4

doi: 10.1016/j.jaad.2008.10.039

Journal of the American Academy of Dermatology
Volume 61, Issue 1 , Pages 117-120 , July 2009